Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA

Biochemistry

Volumn 49, Issue 37, 2010, Pages 8117-8126

  Karalewitz, Andrew P A ^a   Kroken, Abby R ^a   Fu, Zhuji ^a   Baldwin, Michael R ^b   Kim, Jung Ja P ^a   Barbieri, Joseph T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; METABOLITES;

BINDING LOOP; BOTULINUM NEUROTOXINS; CELL BINDING; HOST CELLS; PROTEIN TOXINS; RECEPTOR-BINDING DOMAINS; SEROTYPES; SOUTH AFRICA;

TOXIC MATERIALS;

BOTULINUM TOXIN; BOTULINUM TOXIN C; BOTULINUM TOXIN D; BOTULINUM TOXIN D SA; GANGLIOSIDE; TRYPTOPHAN; UNCLASSIFIED DRUG; BOTULINUM TOXIN TYPE C; NEUROTOXIN; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SEROTYPE; BIOPHYSICS; CHEMISTRY; HUMAN; METABOLISM; NERVE CELL; SOUTH AFRICA;

BIOPHYSICAL PROCESSES; BOTULINUM TOXINS; GANGLIOSIDES; HUMANS; NEURONS; NEUROTOXINS; PROTEIN BINDING; SOUTH AFRICA;

EID: 77956591091     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi100865f     Document Type: Article

References (55)

1. Gill, D. M. (1982) Bacterial toxins: A table of lethal amounts Microbiol. Mol. Biol. Rev. 46, 86-94
2. Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R., and Stevens, R. C. (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity Nat. Struct. Mol. Biol. 5, 898-902
3. Kumaran, D., Eswaramoorthy, S., Furey, W., Navaza, J., Sax, M., and Swaminathan, S. (2009) Domain Organization in Clostridium botulinum Neurotoxin Type E Is Unique: Its Implication in Faster Translocation J. Mol. Biol. 386, 233-245
4. Montecucco, C. and Schiavo, G. (1995) Structure and function of tetanus and botulinum neurotoxins Q. Rev. Biophys. 28, 423-472
5. Montecucco, C. and Schiavo, G. (1993) Tetanus and botulism neurotoxins: A new group of zinc proteases Trends Biochem. Sci. 18, 324-327
6. Brunger, A. T., Breidenbach, M. A., Jin, R., Fischer, A., Santos, J. S., and Montal, M. (2007) Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain PLoS Pathog. 3, e113
7. Verderio, C., Rossetto, O., Grumelli, C., Frassoni, C., Montecucco, C., and Matteoli, M. (2006) Entering neurons: Botulinum toxins and synaptic vesicle recycling EMBO Rep. 7, 995-999
8. Ochanda, J. O., Syuto, B., Ohishi, I., Naiki, M., and Kubo, S. (1986) Binding of Clostridium botulinum Neurotoxin to Gangliosides J. Biochem. 100, 27-33
9. Dong, M., Yeh, F., Tepp, W. H., Dean, C., Johnson, E. A., Janz, R., and Chapman, E. R. (2006) SV2 Is the Protein Receptor for Botulinum Neurotoxin A Science 312, 592-596
10. Dong, M., Tepp, W. H., Liu, H., Johnson, E. A., and Chapman, E. R. (2007) Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons J. Cell Biol. 179, 1511-1522
11. Dong, M., Richards, D. A., Goodnough, M. C., Tepp, W. H., Johnson, E. A., and Chapman, E. R. (2003) Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells J. Cell Biol. 162, 1293-1303
12. Dong, M., Liu, H., Tepp, W. H., Johnson, E. A., Janz, R., and Chapman, E. R. (2008) Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons Mol. Biol. Cell 19, 5226-5237
13. Fu, Z., Chen, C., Barbieri, J. T., Kim, J.-J. P., and Baldwin, M. R. (2009) Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F Biochemistry 48, 5631-5641
14. Montal, M. (2009) Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel Toxicon 54, 565-569
15. Fischer, A. and Montal, M. (2007) Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes Proc. Natl. Acad. Sci. U.S.A. 104, 10447-10452
16. Fischer, A. and Montal, M. (2007) Crucial Role of the Disulfide Bridge between Botulinum Neurotoxin Light and Heavy Chains in Protease Translocation across Membranes J. Biol. Chem. 282, 29604-29611
17. Schiavo, G. G., Benfenati, F., Poulain, B., Rossetto, O., de Laureto, P. P., DasGupta, B. R., and Montecucco, C. (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin Nature 359, 832-835
18. Binz, T., Blasi, J., Yamasaki, S., Baumeister, A., Link, E., Südhof, T. C., Jahn, R., and Niemann, H. (1994) Proteolysis of SNAP-25 by types E and A botulinal neurotoxins J. Biol. Chem. 269, 1617-1620
19. Yamasaki, S., Baumeister, A., Binz, T., Blasi, J., Link, E., Cornille, F., Roques, B., Fykse, E. M., Sahof, T. C., and Jahn, R. (1994) Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin J. Biol. Chem. 269, 12764-12772
20. Blasi, J., Chapman, E. R., Yamasaki, S., Binz, T., Niemann, H., and Jahn, R. (1993) Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin EMBO J. 12, 4821-4828
21. Oguma, K., Yokota, K., Hayashi, S., Takeshi, K., Kumagai, M., Itoh, N., Tachi, N., and Chiba, S. (1990) Infant botulism due to Clostridium botulinum type C toxin Lancet 336, 1449-1450
22. Gangarosa, E. J., Donadio, J. A., Armstrong, R. W., Meyer, K. F., Brachman, P. S., and Dowell, V. R. (1971) Botulism in the United States, 1899-1969 Am. J. Epidemiol. 93, 93-101
23. Coffield, J. A., Bakry, N., Zhang, R. D., Carlson, J., Gomella, L. G., and Simpson, L. L. (1997) In vitro characterization of botulinum toxin types A, C and D action on human tissues: Combined electrophysiologic, pharmacologic and molecular biologic approaches J. Pharmacol. Exp. Ther. 280, 1489-1498
24. Neimanis, A., Gavier-Widen, D., Leighton, F., Bollinger, T., Rocke, T., and Morner, T. (2007) An outbreak of type C botulism in herring gulls (Larus argentatus) in southeastern Sweden J. Wildl. Dis. 43, 327-336
25. Davletov, B., Bajohrs, M., and Binz, T. (2005) Beyond BOTOX: Advantages and limitations of individual botulinum neurotoxins Trends Neurosci. 28, 446-452
26. Brand, C. J., Schmitt, S. M., Duncan, R. M., and Cooley, T. M. (1988) An outbreak of type E botulism among common loons (Gavia immer) in Michigans upper peninsula J. Wildl. Dis. 24, 471-476
27. Tsukamoto, K., Kohda, T., Mukamoto, M., Takeuchi, K., Ihara, H., Saito, M., and Kozaki, S. (2005) Binding of Clostridium botulinum Type C and D Neurotoxins to Ganglioside and Phospholipid J. Biol. Chem. 280, 35164-35171
28. Baldwin, M. R. and Barbieri, J. T. (2007) Association of Botulinum Neurotoxin Serotypes A and B with Synaptic Vesicle Protein Complexes Biochemistry 46, 3200-3210
29. Rummel, A., Hafner, K., Mahrhold, S., Darashchonak, N., Holt, M., Jahn, R., Beermann, S., Karnath, T., Bigalke, H., and Binz, T. (2009) Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor J. Neurochem. 110, 1942-1954
30. Webb, R. P., Smith, T. J., Wright, P. M., Montgomery, V. A., Meagher, M. M., and Smith, L. A. (2007) Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins Vaccine 25, 4273-4282
31. Chen, C., Fu, Z., Kim, J.-J. P., Barbieri, J. T., and Baldwin, M. R. (2009) Gangliosides as High Affinity Receptors for Tetanus Neurotoxin J. Biol. Chem. 284, 26569-26577
32. Minor, W., Tomchick, D., and Otwinowski, Z. (2000) Strategies for macromolecular synchrotron crystallography Structure 8, R105-R110
33. Collaborative Computational Project Number 4 (1994) The CCP4 suite: Programs for protein crystallography Acta Crystallogr. D50, 760-763
34. Brunger, A. T. (2007) Version 1.2 of the Crystallography and NMR system Nat. Protoc. 2, 2728-2733
35. Roussel, A., Fontecilla-Camps, J. C., and Cambillau, C. (1990) CRYStallize: A crystallographic symmetry display and handling subpackage in TOM/FRODO J. Mol. Graphics 8, 86-88
36. Moriishi, K., Koura, M., Abe, N., Fujii, N., Fujinaga, Y., Inoue, K., and Ogumad, K. (1996) Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms Biochim. Biophys. Acta 1307, 123-126
37. Jin, R., Rummel, A., Binz, T., and Brunger, A. T. (2006) Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity Nature 444, 1092-1095
38. Chai, Q., Arndt, J. W., Dong, M., Tepp, W. H., Johnson, E. A., Chapman, E. R., and Stevens, R. C. (2006) Structural basis of cell surface receptor recognition by botulinum neurotoxin B Nature 444, 1096-1100
39. Stenmark, P., Dupuy, J., Imamura, A., Kiso, M., and Stevens, R. C. (2008) Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b: Insight into the toxin-neuron interaction PLoS Pathog. 4, e1000129
40. Rummel, A., Mahrhold, S., Bigalke, H., and Binz, T. (2004) The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction Mol. Microbiol. 51, 631-643
41. Chen, C., Baldwin, M. R., and Barbieri, J. T. (2008) Molecular Basis for Tetanus Toxin Coreceptor Interactions Biochemistry 47, 7179-7186
42. Tsukamoto, K., Kozai, Y., Ihara, H., Kohda, T., Mukamoto, M., Tsuji, T., and Kozaki, S. (2008) Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D Microb. Pathog. 44, 484-493
43. Nuemket, N., Tanaka, Y., Tsukamoto, K., Tsuji, T., Nakamura, K., Kozaki, S., Yao, M., and Tanaka, I. (2010) Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum Acta Crystallogr. F66, 608-610
44. Lacy, D. B. and Stevens, R. C. (1999) Sequence homology and structural analysis of the clostridial neurotoxins J. Mol. Biol. 291, 1091-1104
45. Merritt, E. A., Sarfaty, S., Akker, F. v. d., LHoir, C., Martial, J. A., and Hol, W. G. (1994) Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide Protein Sci. 3, 166-175
46. Zhang, R. G., Scott, D. L., Westbrook, M. L., Nance, S., Spangler, B. D., Shipley, G. G., and Westbrook, E. M. (1995) The three-dimensional crystal structure of cholera toxin J. Mol. Biol. 251, 563-573
47. Varghese, J. N., McKimm-Breschkin, J. L., Caldwell, J. B., Kortt, A. A., and Colman, P. M. (1992) The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor Proteins 14, 327-332
48. Maveyraud, L., Niwa, H., Guillet, V., Svergun, D. I., Konarev, P. V., Palmer, R. A., Peumans, W. J., Rouge, P., Van Damme, E. J., Reynolds, C. D., and Mourey, L. (2009) Structural basis for sugar recognition, including the Tn carcinoma antigen, by the lectin SNA-II from Sambucus nigra Proteins 75, 89-103
49. Hatakeyama, T., Unno, H., Kouzuma, Y., Uchida, T., Eto, S., Hidemura, H., Kato, N., Yonekura, M., and Kusunoki, M. (2007) C-type lectin-like carbohydrate recognition of the hemolytic lectin CEL-III containing ricin-type β-trefoil folds J. Biol. Chem. 282, 37826-37835
50. Kalandakanond, S. and Coffield, J. A. (2001) Cleavage of intracellular substrates of botulinum toxins A, C, and D in a mammalian target tissue J. Pharmacol. Exp. Ther. 296, 749-755
51. Eleopra, R., Tugnoli, V., Rossetto, O., Montecucco, C., and De Grandis, D. (1997) Botulinum neurotoxin serotype C: A novel effective botulinum toxin therapy in human Neurosci. Lett. 224, 91-94
52. Baldwin, M. R., Tepp, W. H., Przedpelski, A., Pier, C. L., Bradshaw, M., Johnson, E. A., and Barbieri, J. T. (2008) Subunit vaccine against the seven serotypes of botulism Infect. Immun. 76, 1314-1318
53. Dolimbek, B. Z., Steward, L. E., Aoki, K. R., and Atassi, M. Z. (2008) Immune recognition of botulinum neurotoxin B: Antibody-binding regions on the heavy chain of the toxin Mol. Immunol. 45, 910-924
54. Dolimbek, B. Z., Aoki, K. R., Steward, L. E., Jankovic, J., and Atassi, M. Z. (2007) Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A Mol. Immunol. 44, 1029-1041
55. Qazi, O., Sesardic, D., Tierney, R., Soderback, Z., Crane, D., Bolgiano, B., and Fairweather, N. (2006) Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: Implications for development of novel tetanus vaccines Infect. Immun. 74, 4884-4891